The article has a pretty balanced view and several of the people asked say that esketamine could have some benefit for some patients. But other than that your

The article has a pretty balanced view and several of the people asked say that esketamine could have some benefit for some patients. But other than that your statement doesn't make a lot of sense. Of course there can be everything wrong with a novel drug that "could" help with edge-cases. Because if you don't know if it helps and if it may harm people - it could very well do more harm than good. That's why we want robust science for new drugs: To decide whether they'll help more than harm.